SCHEMBL19704930

SCHEMBL19704930

CC(C)(F)c1cc(F)ccc1-n1nnc2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNMA1 Q12791 1/20 0.47
▸ ESR1 P03372 1/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ RAB9A P51151 2/20 0.42
▸ NPC1 O15118 1/20 0.42
▸ TSHR P16473 3/20 0.41
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ RECQL P46063 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ SLC9A1 P19634 1/20 0.39
▸ KEAP1 Q14145 1/20 0.39
▸ GAA P10253 2/20 0.39
▸ MGAM O43451 1/20 0.39
▸ AMY1A P0DUB6 1/20 0.39
▸ SI P14410 1/20 0.39
▸ MGAM2 Q2M2H8 1/20 0.39
▸ ALDH1A1 P00352 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15109556 0.75 KCNMA1 (0.50) KCNMA1ESR1KDM4ERAB9ANPC1
SCHEMBL20821949 0.75 KCNMA1 (0.43) KCNMA1KDM4ERAB9ATSHRSMN1; SMN2
SCHEMBL18703939 0.73 GRM2 (0.52) KCNMA1ESR1KDM4ERAB9ANPC1
SCHEMBL25873798 0.72 KCNMA1 (0.50) KCNMA1ESR1KDM4ERAB9ANPC1
SCHEMBL21337802 0.72 KCNMA1 (0.47) KCNMA1ESR1KDM4ERAB9ANPC1
SCHEMBL6528132 0.71 KCNMA1 (0.53) KCNMA1KDM4ERAB9ATSHRSMN1; SMN2
SCHEMBL20821940 0.71 KCNMA1 (0.46) KCNMA1ESR1KDM4ERAB9ATSHR
SCHEMBL10429585 0.70 KCNMA1 (0.55) KCNMA1KDM4ERAB9ATSHRSMN1; SMN2
SCHEMBL12167112 0.70 KCNMA1 (0.42) KCNMA1ESR1KDM4ERAB9ANPC1
SCHEMBL12175671 0.70 KMT2A (0.59) KCNMA1ESR1KDM4ERAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017214367-A1 INHIBITORS OF THE MENIN-MLL INTERACTION VITAE PHARMACEUTICALS, INC. (US) 2017-12-14 — — WO disclosed
Send feedback